Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
40th Annual Meeting and Scientific Exhibition of the American Society of Nephrology
Paradigm Shift in the Treatment of Kidney Disease: SMART Findings
San Francisco, California / November 2-5, 2007
San Francisco - Proteinuria is an independent risk factor for progression of both diabetic and non-diabetic kidney disease as it likely contributes to worsening fibrosis and renal impairment. Lowering proteinuria levels in turn reduces the...
40th Annual Meeting and Scientific Exhibition of the American Society of Nephrology
Hyperphosphatemia and the Dialysis Patient: Focus on Reducing Calcification
San Francisco, California / November 2-5, 2007
San Francisco - Elevated phosphorus levels occurring at kidney failure are associated with increased vascular calcification and cardiovascular events. Presently, in dialysis patients, hyperphosphatemia is usually managed with phosphate...
40th Annual Meeting and Scientific Exhibition of the American Society of Nephrology
Paradigm Shift in Proteinuria Reduction for Patients Living with Chronic Kidney Disease
San Francisco, California / October 31-November 5, 2007
San Francisco - Proteinuria is an independent risk factor for progression of both diabetic and non-diabetic kidney disease (KD) and likely contributes to worsening fibrosis and renal impairment. Lowering proteinuria levels in turn reduces...
Transcatheter Cardiovascular Therapeutics 2007
Contrast Agents: Hemodynamics, Electrolytes and Acute Kidney Injury
Washington, DC / October 20-25, 2007
Washington, DC - High-contrast coronary computed tomographic angiography (CTA) is a breakthrough technology for evaluating cardiac patients noninvasively. The ever-expanding volume of CTA procedures ranges in the millions, corresponding...
44th European Renal Association/European Dialysis and Transplant Association Annual Congress
Balancing Needs and Concerns of Dialysis Patients: Simplified Regimens, Enhanced Patient Compliance
Barcelona, Spain / June 21-24, 2007
Barcelona - About one-third of patients with any chronic condition fail to adhere to their medical regimen as prescribed. Non-adherence is a variable behaviour and is rooted in a patient’s pre-existing set of beliefs about how important a...
National Kidney Foundation Spring 2007 Clinical Meeting
Optimizing Serum Phosphorus Control: Towards Enhanced Compliance
Orlando, Florida / April 10-14, 2007
Orlando - Chronic kidney disease demands optimal management in order to offset a generally poor prognosis. Among the most important elements that require consistent regulation is serum phosphorus. Phosphate binders have long been used to...
22nd European Association of Urology Annual Congress
Targeted Therapy in Advanced Renal Cell Carcinoma: Extending Patients’ Lives
Berlin, Germany / March 21-24, 2007
Berlin - A better understanding of the pathological processes implicated in renal cell carcinoma (RCC) has enabled the development of targeted therapies. Tyrosine kinase inhibitors (TKIs) represent a particularly promising class of...
Nephrogenic Systemic Fibrosis/Nephrogenic Fibrosing Dermopathy: Focus on Gadolinium-based Contrast Media
Philadelphia, Pennsylvania / November 18, 2006
EDITORIAL OVERVIEW: Dr. James A. Tumlin Director of Clinical Research Southeast Renal Associates Associate Professor of Medicine University of North Carolina at Charlotte Charlotte, North Carolina PANEL Dr. Stanley Goldfarb University of...
39th Annual Meeting and Scientific Exhibition of the American Society of Nephrology
Renin and Blood Pressure Regulation: Protecting the Kidney and the Heart
San Diego, California / November 14-19, 2006
San Diego - Inhibition of the renin-angiotensin system with either an ACE inhibitor or an angiotensin II receptor blocker (ARB) significantly attenuates the development of microalbuminuria, a marker of impending kidney and cardiovascular...